sulfinpyrazone has been researched along with Cardiac Failure in 6 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, AJ | 1 |
| Greco, R | 1 |
| Siciliano, S | 1 |
| Gentile, F | 1 |
| Elia, L | 1 |
| Murena, E | 1 |
| Forni, N | 1 |
| Boccalatte, A | 1 |
| Marsico, F | 1 |
| Smith, JW | 1 |
| Held, K | 1 |
| Howard, T | 1 |
| Hoy, RH | 1 |
| Warren, S | 1 |
| Georgiev, M | 1 |
| Selinger, H | 1 |
1 review available for sulfinpyrazone and Cardiac Failure
| Article | Year |
|---|---|
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
5 other studies available for sulfinpyrazone and Cardiac Failure
| Article | Year |
|---|---|
[Prevention of ischemic cardiopathy, with special reference to secondary prevention in the post-infarct period].
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Heart Failure; Humans; Hyperlipidemias; Hyperte | 1981 |
Mortality after recovery from myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardi | 1980 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; H | 1983 |
Acute renal dysfunction due to sulfinpyrazone therapy in post-myocardial infarction cardiomegaly: reversible hypersensitive interstitial nephritis.
Topics: Aged; Heart Failure; Humans; Kidney Medulla; Male; Middle Aged; Myocardial Infarction; Nephritis, In | 1981 |
[Drug interactions in therapy of cardiac decompensation].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Digoxin; Diuretics; Drug Interact | 1994 |